Pharma
Anna Dover, director of product management at FDB, formerly First Data Bank, says drug-related clinical decision support alerts pose challenges for prescribers and pharmacists, but technology can optimize the process through refinement.
Naomi Fried, founder and CEO of PharmStars, discusses the 13 startups from its spring cohort and its call for applications for its fall 2023 cohort, Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.
HIMSS23
Dr. Colin Banas, chief medical officer at DrFirst, discusses how his company uses AI to automate tasks such as processing prescription refills, which prevents medication errors and reduces clinicians' administrative burden.
HIMSS23
Anna Dover, director of product management at First Databank, discusses First Databank's medication decision support technology, which helps keep clinicians informed about prescription drug information without overwhelming them.
HIMSS23
Wendy Paul, medication process architect at Seattle Children's Hospital, and Kyle Longhurst, product manager at Pariveda, preview their HIMSS23 discussion on a discharge medication error quality improvement project.
Data containing accurate medication history and prescription fill insights can lead to better patient outcomes, says Dr. Colin Banas, CMO of health IT company DrFirst.
HIMSS22
First Databank president Bob Katter discusses the FDB Vela electronic prescribing network and how it will give patients with more control over their prescriptions.
Also: Truepill launches a COVID-19 test coverage platform for insurers, and 23andMe extends its partnership with GSK.
HIMSS21
Dr. Adrian Zai talks about how Massachusetts General Hospital and AstraZeneca have recently worked together.
HIMSS21
Naomi Fried, founder and CEO of PharmStars, discusses how her company mentors digital health startups and coaches pharma executives to prepare both parties for successful partnerships.